SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615774-15-000353
Filing Date
2015-02-24
Accepted
2015-02-24 16:49:49
Documents
3
Period of Report
2015-02-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K s100797_8k.htm 8-K 27288
2 EXHIBIT 99.1 s100797_ex99-1.htm EX-99.1 96189
3 GRAPHIC logo.jpg GRAPHIC 5195
  Complete submission text file 0001615774-15-000353.txt   132092
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 15644163
SIC: 2834 Pharmaceutical Preparations